Trial of biodegradable microspheres for liver cancer
Part of Cancer clinical trials.
This trial tests a new type of biodegradable microsphere for treating liver cancer that cannot be removed with surgery. The microspheres are injected into the liver's blood supply to block tumors and deliver chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have liver cancer that is stage Ib to IIIa and cannot be treated with surgery, transplant, or ablation.
- You are able to undergo a procedure called TACE (chemoembolization).
- You have at least one tumor that is 3 cm or larger but no bigger than 10 cm.
- If you have hepatitis B or C, you are willing to take antiviral medicine during the study.
- Your overall health is good (ECOG score 0-2) and your liver function is stable (Child-Pugh A or B).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new gel-like treatment to standard beads for blocking the blood supply to liver tumors during TACE. It may be an option for patients with certain stages of liver cancer who cannot have surgery or other standard treatments.
This trial tests a new heat-sensitive embolic agent used during TACE (a procedure that blocks blood flow to tumors and delivers chemotherapy directly to the liver) for primary liver cancer. It aims to see if the agent is safe and effective for patients who need TACE treatment.
This trial is for people with advanced liver cancer (HCC) that has spread outside the liver or into major blood vessels. It tests combining a procedure called TACE with immunotherapy (PD-1/PD-L1 inhibitors) and targeted drugs to see how well they work together.
This trial compares two types of tiny beads used in a liver cancer treatment called TACE to see which works better. If you have liver cancer that needs TACE and your liver is still working fairly well, you may be able to join.
This trial studies a new type of “degradable” chemo bead delivered through a catheter to treat hepatocellular carcinoma (HCC). It aims to check safety and whether the treatment works when surgery or transplant is not an option.
This trial tests an affordable, Indian-made treatment for liver cancer (HCC) that can't be surgically removed. Tiny beads (microspheres) are injected into the liver's blood supply to directly deliver radiation to the tumor, potentially shrinking it and slowing the cancer.
Hear when a new Hepatocellular Carcinoma Non-resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.